Cannabinoid CB1 and CB2 Receptor Ligand Specificity and the Development of CB2-Selective Agonists

By  

Current Medicinal Chemistry, Vol. 15, Iss. 14, 2008-06 ,pp. : 1428-1443

Bentham Science Publishers

Access to resources Recommend Favorite

Cannabinoid 1 (CB1) Receptor - Pharmacology, Role in Pain and Recent Developments in Emerging CB1 Agonists

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 5, 2011-08 ,pp. : 536-544

Bentham Science Publishers

Access to resources Recommend Favorite

Updating the Chemistry and Biology of Cannabinoid CB2 Receptor- Specific Inverse Agonists

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 8, 2010-06 ,pp. : 768-778

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands

By  

Current Medicinal Chemistry, Vol. 21, Iss. 2, 2014-01 ,pp. : 187-203

Bentham Science Publishers

Access to resources Recommend Favorite

Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB 1 /CB 2 receptors

By Brooks J.W.   Pryce G.   Bisogno T.   Jaggar S.I.   Hankey D.J.R.   Brown P.   Bridges D.   Ledent C.   Bifulco M.   Rice A.S.C.   Di Marzo V.   Baker D.  

European Journal of Pharmacology, Vol. 439, Iss. 1, 2002-03 ,pp. : 83-92

Elsevier

Access to resources Recommend Favorite